Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. GeneDx Holdings Corp shares valued at $294,654 were sold by Stueland Katherine on Oct 29 ’25. At $136.54 per share, Stueland Katherine sold 2,158 shares. The insider’s holdings dropped to 3,436 shares worth approximately $0.47 million following the completion of this transaction.
Also, Feeley Kevin sold 388 shares, netting a total of over 52,978 in proceeds. Following the sale of shares at $136.54 each, the insider now holds 3,757 shares.
Before that, Stueland Katherine had sold 12,858 shares from its account. In a trade valued at $1,390,911, the CHIEF EXECUTIVE OFFICER traded GeneDx Holdings Corp shares for $108.17 each. Upon closing the transaction, the insider’s holdings decreased to 12,858 shares, worth approximately $0.24 million.
As published in their initiating research note from Canaccord Genuity on October 20, 2025, GeneDx Holdings Corp [WGS] has been a Buy and the price target has been revised to $155. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in early July. As of May 15, 2025, Guggenheim has initiated its “Buy” rating for WGS. Earlier on May 09, 2025, Jefferies upgraded its rating. Their new recommendation was “a Buy” for WGS stock which previously was a “a Hold”.
Analyzing WGS Stock Performance
On last trading session, GeneDx Holdings Corp [NASDAQ: WGS] plunged -1.87% to $136.87. The stock’s lowest price that day was $133.0, but it reached a high of $139.26 in the same session. During the last five days, there has been a surge of approximately 3.88%. Over the course of the year, GeneDx Holdings Corp shares have jumped approximately 76.06%. Shares of the company reached a 52-week high of $146.00 on 10/28/25 and a 52-week low of $55.17 on 05/08/25.
Support And Resistance Levels for GeneDx Holdings Corp (WGS)
According to the 24-hour chart, there is a support level at 133.49, which, if violated, would cause prices to drop to 130.12. In the upper region, resistance lies at 139.75. The next price resistance is at 142.64. RSI (Relative Strength Index) is 61.00 on the 14-day chart, showing neutral technical sentiment.
Is GeneDx Holdings Corp subject to short interest?
Stocks of GeneDx Holdings Corp saw a sharp steep in short interest on 2025-10-15 dropping by -0.61 million shares to 3.0 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 3.61 million shares. A decline of -20.32% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.06 of the overall float, the days-to-cover ratio (short ratio) decline to 6.06.
Which companies own the most shares of GeneDx Holdings Corp (WGS)?
In terms of GeneDx Holdings Corp share price expectations, FactSet research, analysts set an average price target of 162.5 in the next 12 months, up nearly 16.5% from the previous closing price of $139.49. Analysts anticipate GeneDx Holdings Corp stock to reach 170 by 2025, with the lowest price target being 120. In spite of this, 3 analysts ranked GeneDx Holdings Corp stock as Buy at the end of 2025. On August 28, 2024, Wells Fargo assigned a price target of “an Equal weight” to the stock and initiated coverage with a $34.
